Elder Pharma in deal with Italian company
Elder Pharmaceuticals on Monday said it has signed an in-licensing agreement with Gnosis of Italy.
By PTI |
MUMBAI: Elder Pharmaceuticals on Monday said it has signed an in-licensing agreement with Gnosis of Italy.
Under the agreement, Gnosis has licensed an anti-osteoarthritic nutritional supplement, S-Adenosyl methionine, and would supply the product in finished form to be marketed in India.
The market for anti-arthritic products in India is about Rs 600 crore and is showing a good growth, Elder said in a statement here.
Osteoarthritis is one of the most prevalent joint disorders, especially in middle-aged and elderly people, it said.
Under the agreement, Gnosis has licensed an anti-osteoarthritic nutritional supplement, S-Adenosyl methionine, and would supply the product in finished form to be marketed in India.
The market for anti-arthritic products in India is about Rs 600 crore and is showing a good growth, Elder said in a statement here.
Osteoarthritis is one of the most prevalent joint disorders, especially in middle-aged and elderly people, it said.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
